Izcue Ana, Coombes Janine L, Powrie Fiona
Sir William Dunn School of Pathology, University of Oxford, Oxford, OX1 3RE, UK.
Annu Rev Immunol. 2009;27:313-38. doi: 10.1146/annurev.immunol.021908.132657.
The immune system is pivotal in mediating the interactions between host and microbiota that shape the intestinal environment. Intestinal homeostasis arises from a highly dynamic balance between host protective immunity and regulatory mechanisms. This regulation is achieved by a number of cell populations acting through a set of shared regulatory pathways. In this review, we summarize the main lymphocyte subsets controlling immune responsiveness in the gut and their mechanisms of control, which involve maintenance of intestinal barrier function and suppression of chronic inflammation. CD4(+)Foxp3(+) T cells play a nonredundant role in the maintenance of intestinal homeostasis through IL-10- and TGF-beta-dependent mechanisms. Their activity is complemented by other T and B lymphocytes. Because breakdown in immune regulatory networks in the intestine leads to chronic inflammatory diseases of the gut, such as inflammatory bowel disease and celiac disease, regulatory lymphocytes are an attractive target for therapies of intestinal inflammation.
免疫系统在介导宿主与微生物群之间的相互作用以塑造肠道环境方面起着关键作用。肠道稳态源于宿主保护性免疫与调节机制之间高度动态的平衡。这种调节是通过一系列细胞群体通过一组共享的调节途径来实现的。在本综述中,我们总结了控制肠道免疫反应性的主要淋巴细胞亚群及其控制机制,其中包括维持肠道屏障功能和抑制慢性炎症。CD4(+)Foxp3(+) T细胞通过依赖白细胞介素-10和转化生长因子-β的机制在维持肠道稳态中发挥不可替代的作用。它们的活性得到其他T淋巴细胞和B淋巴细胞的补充。由于肠道免疫调节网络的破坏会导致肠道慢性炎症性疾病,如炎症性肠病和乳糜泻,调节性淋巴细胞是肠道炎症治疗的一个有吸引力的靶点。